Hypertension is one of the most common diseases in China. It is estimated that 160 million people in China are suffering from hypertension. However, for various reasons ranging from widespread misunderstandings about the disease to disparity in patient experiences, hypertension is poorly controlled in China with overall control rate at only 6%, resulting enormous burden of health care expenses both on individual and the society.
To better control hypertension, it is crucial to improve physiciansĄŻ knowledge and skills dealing with the disease. Since founded in 2002 by the CMDA and Peking University People's Hospital, China Cardiovascular & Cerebrovascular Congress (the congress) has provided a platform for Chinese physicians to share therapeutic strategies to control hypertension, stroke and related complications. In the past 6 years, the congress has become one of the top conferences in Cardiovascular & Cerebrovascular area - 1500 heart physicians, neurologists, endocrinologists and hypertension specialists from across the country attended the congress in 2008.
The 7th China Cardiovascular & Cerebrovascular Congress will be held September 18-20, 2009 in Beijing. The theme of this conference is: The Heart, Metabolic disorders and Stroke. Through a number of inter-disciplinary in-depth studies, the congress intends to the Congress intends to illustrate the fundamental pathophysiological mechanisms of Cardiovascular & Cerebrovascular diseases.
The congress sincerely invites experts and researchers in the field joining our efforts to mitigate these threats to our lives. The congress strives to provide a professional forum for cardiovascular and cerebrovascular specialists, neurologists and researchers in related fields both nationally and internationally, making the China Cardiovascular & Cerebrovascular Congress a global player.